CA
CYTK icon

Clearstead Advisors’s Cytokinetics CYTK Stock Holding History

Clearstead Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.59K Sell
100
-570
-85% -$36.2K ﹤0.01% 1690
2025
Q4 		$42.6K Buy
670
+330
+97% +$20.5K ﹤0.01% 1470
2025
Q3 		$18.7K Hold
340
– – ﹤0.01% 1669
2025
Q2 		$11.2K Buy
340
+327
+2,515% +$11.4K ﹤0.01% 1849
2025
Q1 		$523 Buy
+13
New +$597 ﹤0.01% 2066
2024
Q4 		– Sell
-584
Closed -$30.8K – 2114
2024
Q3 		$30.8K Buy
584
+185
+46% +$10.3K ﹤0.01% 1315
2024
Q2 		$21.6K Buy
399
+64
+19% +$3.86K ﹤0.01% 1358
2024
Q1 		$19.4K Buy
+335
New +$25.9K ﹤0.01% 950

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return